Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo

Lorenzo Agoni, Indranil Basu, Seema Gupta, Alan Alfieri, Angela Gambino, Gary L. Goldberg, E. Premkumar Reddy, Chandan Guha

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences